<p>Incremental cost-effectiveness ratios for various available insulin regimens, by country.</p>

NIAID Data Ecosystem2026-05-10 收录

数据链接：

https://figshare.com/articles/dataset/_p_Incremental_cost-effectiveness_ratios_for_various_available_insulin_regimens_by_country_p_/30989594 数据链接链接失效反馈

官方服务：

资源简介：

Incremental cost-effectiveness ratios for various available insulin regimens, by country.

创建时间：

2026-01-02

Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study - supplementary table

心衰治疗成本分析

药物经济学评估

Aim: Compare heart failure (HF) costs of Furoscix use at home compared with inpatient intravenous (IV) diuresis. Patients & methods: Prospective, case control study of chronic HF pat

DataCite Commons2024-05-17 更新100

Study 200977: Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the Treatment of Subjects With Type 2 Diabetes Mellitus: The Switch Study

糖尿病治疗优化

GLP-1受体激动剂疗效

This Phase IIIb, randomized, open-label, parallel group, active control, multicenter, treat to-target study of 26 weeks' treatment duration will evaluate the efficacy and safety of once-weekly albiglu

DataCite Commons2025-12-08 更新10

Healthcare resource utilization and expenditures among newly-diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants

药物经济学评估

心血管病治疗优化

Aims: Non-valvular atrial fibrillation (NVAF) prevalence increases with age. Hence, evaluating the economic burden among older-aged patients is vital. This study aimed to compare healthcare res

Taylor & Francis Group2024-02-28 更新10

Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study

药物经济学评估

肺癌靶向治疗可及性

ABSTRACT BACKGROUND: Lung cancer is the fourth most common cancer in Brazil. In the 2000s, better understanding of molecular pathways led to development of epidermal growth factor receptor (EGFR)-ta

NIAID Data Ecosystem20

Table 1_Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis.docx

药物经济学评估

COVID-19治疗

IntroductionRemdesivir (RDV) and nirmatrelvir/ritonavir (NRM/RTV) are two antiviral agents for treating outpatient adults with mild to moderate symptomatic COVID-19 at high risk of developing a severe

NIAID Data Ecosystem10

<p>Incremental cost-effectiveness ratios for various available insulin regimens, by country.</p>

资源简介：

相关数据集